|
|
||||||||
Original Report |
1 Department of Radiology, Cappagh National Orthopaedic Hospital, Finglas,
Dublin 11, Ireland.
2 Department of Radiology, Mater Misericordiae Hospital, Eccles St., Dublin 7,
Ireland.
3 Department of Neurology, Mater Misericordiae Hospital, Dublin 7,
Ireland.
4 Department of Rheumatology, Mater Misericordiae Hospital, Dublin 7,
Ireland.
Received October 11, 2001;
accepted after revision April 4, 2002.
Address correspondence to M. J. O'Connell.
Abstract
|
|
|---|
CONCLUSION. Whole-body turbo short tau inversion recovery imaging is a convenient complete method of evaluating patients with muscle inflammation caused by polymyositis. This imaging technique allows us to evaluate the total inflammatory burden by revealing multiple muscle groups not seen with standard protocols.
|
|
|---|
|
|
|---|
Methods
All images were acquired on either a Harmony 1.5-T system (Siemens,
Erlangen, Germany) or a Gyroscan 1.5-T system (Phillips Medical Systems, Best,
The Netherlands). Imaging was performed in the coronal plane using a turbo
STIR technique. Both excitation and signal acquisition were achieved with a
body coil. Initial survey scans using sagittal and coronal localizers were
obtained. Next, turbo STIR images were acquired using a TR of 4000 msec, a TE
of 40 msec, and an echo-train length or turbo factor of 6. Fat suppression was
obtained with a 180° inversion pulse, followed by tissue excitation after
160 msec. To achieve whole-body coverage, coronal slabs were acquired at four
stations using a field of view of 50 cm. The number of coronal slices at each
station varied according to patient body habitus. Slice thickness was 8 mm
with interslice spacing of 0.8 mm. Respiratory triggering was used.
A whole-body image was obtained after imaging by manual image realignment and cropping at a workstation before presentation to the referring clinician. Both the individual coronal sections and the generated whole-body scans were reviewed by the interpreting radiologist to facilitate diagnosis. After the whole-body MR study, muscle biopsy guided by scanning findings was performed.
Image Interpretation
Two independent reviewers analyzed images at a workstation by studying
individual image sections separately, noting the distribution of muscle
inflammation and examining for evidence of underlying neoplastic disease.
Differences in observations were resolved by consensus at a second film
review.
|
|
|---|
|
|
|
|
|
|
|
|
|
|---|
The diagnosis of polymyositis is based on a typical clinical presentation, serum skeletal muscle enzyme levels, and findings on electromyography and muscle biopsy. Clinical presentation of a symmetric proximal myositis is not always apparent. Patients with atypical presentations of this disease have dysphagia, due to involvement of muscles of the pharynx and the upper esophagus, and myositis of neck flexor muscles [1]. This presentation gives a clinical differential diagnosis of motor neuron disease and myasthenia gravis. Depicting a typical distribution of muscle inflammation in limb muscles on whole-body MR imaging has the potential to help establish the diagnosis of polymyositis.
Potential pitfalls occur in the laboratory diagnosis of polymyositis because serum skeletal muscle enzyme levels can be normal and electromyography findings are not specific [7]. Electromyography causes patient discomfort and is time-consuming for the operator, and postprocedural focal myositis interferes with the interpretation of subsequent biopsy findings. Similarly, iatrogenic electromyography-induced inflammation should not be confused with polymyositis on MR imaging (Fig. 5). Muscle biopsy is expensive, causes morbidity in patients who may be severely ill, and can delay mobilization and interfere with physiotherapeutic interventions. Biopsy has a false-negative rate of 10-25% [7, 9]. MR imaging has previously been documented to reduce this rate when imaging is used to identify the biopsy site [9], and whole-body MR imaging has the potential to provide a wider survey of these potential sites.
|
Conventional imaging methods of documenting polymyositis include limited scanning of the proximal lower limb muscle girdle and scanning of the proximal upper limb girdle if the patient is symptomatic at this site. MR imaging techniques include coronal T1-weighted, STIR, and axial T2-weighted sequences [10]. The technique of STIR imaging has been shown to have 97% specificity for identifying sites of inflammatory myopathy proven at biopsy [6]. However, the findings are not specific [11]. Gadolinium-enhanced T1-weighted MR imaging has no advantage over the STIR technique [11]. Myositis seen in patients with polymyositis typically has a high signal on T2-weighted and STIR images in the muscle body, although inflammation may also be seen in a myofascial distribution around muscles [11]. T1-weighted images show isointensity in regions of inflammation that have been described to involve initially the vastus medialis and lateralis muscles [10]. Although the inflammation is clinically symmetric and classically involves the proximal muscle groups, muscle involvement can be patchy and asymmetric on imaging, and distal muscles of the upper and lower limbs may be involved [11]. High signal intensity on T2-weighted and STIR sequences is also seen in the subcutaneous tissues, with thickened connective tissue septa [11]. This involvement is present in both polymyositis and dermatomyositis, but only the latter has the characteristic skin rash. In an effort to explain why findings on imaging may be normal, Huppertz and Kaiser [12] have suggested that MR imaging findings in patients with myositis may lag behind clinical or serologic improvement.
A limitation of conventional MR imaging has been an inability to scan a large volume of muscles without prolonged acquisition times. In general, only symptomatic muscles were imaged. In our study, myositis was frequently identified in asymptomatic muscle groups. Whole-body MR imaging has the advantage of documenting inflammatory myopathy of multiple muscle groups, including the psoas, intercostal, and neck muscles, not imaged using standard protocols. To our knowledge, inflammation in these muscle groups has never been previously documented on MR imaging in polymyositis. In addition, the distal upper and lower limb muscles can be imaged with little extra scanning time. Upper limb position is dictated by the patient body habitus. In most cases, the patient's arms are placed by the side, but they can be placed across the chest or above the head, the latter requiring an extra coronal acquisition.
Whole-body scanning gives a complete assessment of disease burden in an acute presentation, therefore helping the clinician decide what level of treatment is appropriate. It also has the potential to identify associated malignancy in patients with paraneoplastic polymyositis. This advantage may obviate an extensive search for an unknown primary tumor by conventional scanning techniques.
In the follow-up treatment of patients with polymyositis, frequent diagnostic dilemmas occur as to whether the disease is still active after antiinflammatory treatment. Determining serum skeletal muscle enzymes levels is of limited value [1]. Assessment of disease activity and sequelae is complicated because a validated comparative measure has not been developed for grading disease severity and for follow-up [7]. In the past, these problems have sometimes led to repeated biopsy. Whole-body MR imaging has the potential to document a response to treatment. In addition, it may prove useful in differentiating persistent inflammatory myositis and steroid myopathy, which cause fatty infiltration and atrophy and are best diagnosed on additional T1-weighted MR imaging [11].
Our study shows a wide variation in distribution of muscle inflammation in patients with polymyositis. It also identifies relative sparing of certain muscle groups, including the adductor magnus and hip extensor muscles, seen in one patient. Surveillance scanning could help improve our understanding of the natural history of polymyositis.
In summary, we report the novel application of a whole-body MR imaging protocol using fat-suppressed STIR images that can be rapidly acquired to facilitate a global overview of the extent and symmetry of muscle disease. We advocate its use as the primary diagnostic imaging tool in the evaluation of patients referred for suspected polymyositis.
|
|
|---|
This article has been cited by other articles:
![]() |
M.-A. Weber, M. Krix, U. Jappe, H. B. Huttner, M. Hartmann, U. Meyding-Lamade, M. Essig, C. Fiehn, H.-U. Kauczor, and S. Delorme Pathologic Skeletal Muscle Perfusion in Patients with Myositis: Detection with Quantitative Contrast-enhanced US--Initial Results Radiology, December 21, 2005; (2005) 2382041822. [Abstract] [Full Text] |
||||
![]() |
I. Postolov, M. J. Rasiej, D. Hershman, A. P. Hays, and J. H. M. Austin Thoracoabdominal Muscular Enlargement in Dermatomyositis: CT Visualization Am. J. Roentgenol., March 1, 2005; 184(3_supp): S91 - S93. [Full Text] [PDF] |
||||
![]() |
C. J. Kellenberger, M. Epelman, S. F. Miller, and P. S. Babyn Fast STIR Whole-Body MR Imaging in Children RadioGraphics, September 1, 2004; 24(5): 1317 - 1330. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J Eustace and E. Nelson Whole body magnetic resonance imaging BMJ, June 12, 2004; 328(7453): 1387 - 1388. [Full Text] [PDF] |
||||
![]() |
G. Hargaden, M. O'Connell, E. Kavanagh, T. Powell, R. Ward, and S. Eustace Current Concepts in Whole-Body Imaging Using Turbo Short Tau Inversion Recovery MR Imaging Am. J. Roentgenol., January 1, 2003; 180(1): 247 - 252. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |